Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nonmyeloablative HSCT with TLI and ATG vs Standard Care in AML
NCT00568633Phase 3Terminated
- Sponsor
- Stanford University
- Start
- Aug 2007
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of antithymocyte globulin rabbit in acute myeloid leukemia (AML), sponsored by Stanford University. Started Aug 2007; status: terminated.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00568633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00568633.